secwatch / observer
8-K filed March 28, 2022, 7:59 PM ET ticker BIO CIK 0000012208
leadership confidence high sentiment neutral materiality 0.30

Co-founder Alice Schwartz to leave Bio-Rad board; appointed Director Emeritus

BIO-RAD LABORATORIES, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Alice N. Schwartz

Director
BIO · BIO-RAD LABORATORIES, INC.
Effective
2022-04-26
Filed
March 28, 2022, 7:59 PM ET
On March 23, 2022, Alice N. Schwartz, a director and co-founder of Bio-Rad Laboratories, Inc. (the “Company”), informed the Company of her decision not to stand for re-election to the Company’s Board of Directors at the 2022 Annual Meeting of Stockholders.
Appointed

Alice N. Schwartz

Director Emeritus
BIO · BIO-RAD LABORATORIES, INC.
Effective
2022-04-26
Filed
March 28, 2022, 7:59 PM ET
On March 23, 2022, the Company’s Board of Directors appointed Mrs. Schwartz as a Director Emeritus, effective as of April 26, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alice N. Schwartz departed as Director at BIO-RAD LABORATORIES, INC..

Action
not stand for re-election
Role
Director
Exact text from the filing
On March 23, 2022, Alice N. Schwartz, a director and co-founder of Bio-Rad Laboratories, Inc. (the “Company”), informed the Company of her decision not to stand for re-election to the Company’s Board of Directors at the 2022 Annual Meeting of Stockholders.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Alice N. Schwartz was appointed as Director Emeritus at BIO-RAD LABORATORIES, INC..

Action
appointed
Role
Director Emeritus
Exact text from the filing
On March 23, 2022, the Company’s Board of Directors appointed Mrs. Schwartz as a Director Emeritus, effective as of April 26, 2022.
View on SEC.gov

BIO-RAD LABORATORIES, INC. filing history →

Source: SEC EDGAR
accession 0001193125-22-086770
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.